An updated clinical guideline addresses the natural history and medical and surgical management of Crohn disease.
Sponsoring Organization: American College of Gastroenterology (ACG)Target Audience: Gastroenterology clinical providers
Background and Objective
The ACG has updated its clinical guideline based on an evidence-based review of the epidemiology and medical and surgical management of Crohn disease in adults.
What's Changed
Since the previous guideline was published in 2009, advances in diagnostic testing, endoscopic techniques, and therapeutics have made this guideline update necessary. Noninvasive stool tests can help monitor clinical activity, biologics with differing mechanisms of action are now available and approved, and drug assays for therapeutic drug monitoring all have made their way into current disease management.
Key Recommendations
Reviewing Author
DisclosuresConsultant/Advisory BoardAbbVie; UpToDate; Spherix Health; Samsung Bioepis
Grant/Research SupportCrohns and Colitis Foundation
Leadership Positions in Professional SocietiesAmerican College of Gastroenterology (Immediate Past President)
DisclosuresConsultant/Advisory BoardAbbVie; UpToDate; Spherix Health; Samsung Bioepis
Grant/Research SupportCrohns and Colitis Foundation
Leadership Positions in Professional SocietiesAmerican College of Gastroenterology (Immediate Past President)